What is AbbVie's liletta — finite-lived intangible assets, net?

AbbVie (ABBV) reported liletta — finite-lived intangible assets, net of $561.00M in Q4 2023.

What does liletta — finite-lived intangible assets, net mean?

The remaining book value of the Liletta product's intellectual property after accounting for amortization and impairment.

Discontinued — last reported Q4 '23

Products & Services · Finite-Lived Intangible Assets, Net

Liletta — Finite-Lived Intangible Assets, Net

Analysis

StatementSegment

CategoryEfficiency

SignalContext dependent

VolatilityModerate

First reportedQ4 2023

Last reportedQ4 2023Feb 20, 2026

Rolls up toIntangibles (Net)

How to read this metric

A steady decline is expected due to amortization, while a sudden drop may signal an impairment charge, and an increase typically reflects additional capital investment or acquisitions.

Detailed definition

This metric represents the carrying value of the Liletta product line's finite-lived intangible assets on the balance sh...

Peer comparison

Comparable to net intangible asset balances for specific product lines or acquired portfolios reported by other life sciences companies.

Metric ID: abbv_segment_liletta_finite_lived_intangible_assets_net

Historical Data

1 periods

	Q4 '23
Value	$561.00M

Similar Metrics at Other Companies

Raymond James FinancialRJF View metric

BiogenBIIB View metric

MKS InstrumentsMKSI View metric

ViatrisVTRS View metric

MKS InstrumentsMKSI View metric

Frequently Asked Questions

What is AbbVie's liletta — finite-lived intangible assets, net?: AbbVie (ABBV) reported liletta — finite-lived intangible assets, net of $561.00M in Q4 2023.
What does liletta — finite-lived intangible assets, net mean?: The remaining book value of the Liletta product's intellectual property after accounting for amortization and impairment.